These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15729518)

  • 1. Intrathecal sICAM-1 production in multiple sclerosis--correlation with triple dose Gd-DTPA MRI enhancement and IgG index.
    Acar G; Idiman F; Kirkali G; Ozakbaş S; Oktay G; Cakmakçi H; Idiman E
    J Neurol; 2005 Feb; 252(2):146-50. PubMed ID: 15729518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis: correlation with Gd-DTPA magnetic resonance imaging-enhancement and cerebrospinal fluid findings.
    Trojano M; Avolio C; Simone IL; Defazio G; Manzari C; De Robertis F; Calò A; Livrea P
    Neurology; 1996 Dec; 47(6):1535-41. PubMed ID: 8960741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum soluble intercellular adhesion molecule-I in MS: relation to clinical and Gd-MRI activity and to rIFN beta-Ib treatment.
    Trojano M; Avolio C; Ruggieri M; Defazio G; Giuliani F; Paolicelli D; Livrea P
    Mult Scler; 1998 Jun; 4(3):183-7. PubMed ID: 9762671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging.
    Giovannoni G; Lai M; Thorpe J; Kidd D; Chamoun V; Thompson AJ; Miller DH; Feldmann M; Thompson EJ
    Neurology; 1997 Jun; 48(6):1557-65. PubMed ID: 9191766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial analysis of soluble intercellular adhesion molecule-1 level in relapsing-remitting multiple sclerosis patients during IFN-beta1b treatment.
    Kilinc M; Saatci-Cekirge I; Karabudak R
    J Interferon Cytokine Res; 2003 Mar; 23(3):127-33. PubMed ID: 12716484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis.
    Khoury SJ; Orav EJ; Guttmann CR; Kikinis R; Jolesz FA; Weiner HL
    Neurology; 1999 Sep; 53(4):758-64. PubMed ID: 10489037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD8 and ICAM-1 in serum and CSF of MS patients treated with 6-methylprednisolone.
    Franciotta D; Piccolo G; Zardini E; Bergamaschi R; Cosi V
    Acta Neurol Scand; 1997 May; 95(5):275-9. PubMed ID: 9188901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical course and changes of soluble interleukin-2 receptor and soluble forms of intercellular adhesion molecule-1 (ICAM-1) in serum of multiple sclerosis patients].
    Bilińska M; Frydecka I; Podemski R
    Neurol Neurochir Pol; 2001; 35(1):47-56. PubMed ID: 11464716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosis.
    Rieckmann P; Altenhofen B; Riegel A; Kallmann B; Felgenhauer K
    Mult Scler; 1998 Jun; 4(3):178-82. PubMed ID: 9762670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the clinical utility of cerebrospinal fluid (CSF) indices of inflammatory markers in multiple sclerosis.
    McMillan SA; McDonnell GV; Douglas JP; Hawkins SA
    Acta Neurol Scand; 2000 Apr; 101(4):239-43. PubMed ID: 10770519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis.
    Rieckmann P; Altenhofen B; Riegel A; Baudewig J; Felgenhauer K
    Ann Neurol; 1997 Mar; 41(3):326-33. PubMed ID: 9066353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of vascular cell adhesion molecule-1.
    Droogan AG; McMillan SA; Douglas JP; Hawkins SA
    J Neuroimmunol; 1996 Feb; 64(2):185-91. PubMed ID: 8632061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide as an activity marker in multiple sclerosis.
    Acar G; Idiman F; Idiman E; Kirkali G; Cakmakçi H; Ozakbaş S
    J Neurol; 2003 May; 250(5):588-92. PubMed ID: 12736739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS.
    Trojano M; Avolio C; Liuzzi GM; Ruggieri M; Defazio G; Liguori M; Santacroce MP; Paolicelli D; Giuliani F; Riccio P; Livrea P
    Neurology; 1999 Oct; 53(7):1402-8. PubMed ID: 10534242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration of soluble adhesion molecules (sVCAM-1, sICAM-1 and sL-selectin) in the cerebrospinal fluid and serum of patients with multiple sclerosis and systemic lupus erythematosus with central nervous involvement.
    Baraczka K; Nékám K; Pozsonyi T; Jakab L; Szongoth M; Seszták M
    Neuroimmunomodulation; 2001; 9(1):49-54. PubMed ID: 11435752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible role of transforming growth factor-beta in relapsing-remitting multiple sclerosis.
    Carrieri PB; Provitera V; Bruno R; Perrella M; Tartaglia G; Busto A; Perrella O
    Neurol Res; 1997 Dec; 19(6):599-600. PubMed ID: 9427959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal IgM index correlates with a severe disease course in multiple sclerosis: Clinical and MRI results.
    Ozakbas S; Cinar BP; Özcelik P; Baser H; Kosehasanoğullari G
    Clin Neurol Neurosurg; 2017 Sep; 160():27-29. PubMed ID: 28622533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of soluble ICAM-1 and TNFalphaR in the cerebrospinal fluid and serum levels in a population of Brazilian patients with relapsing-remitting multiple sclerosis.
    Alves-Leon SV; Batista E; Papais-Alvarenga R; Quírico-Santos T
    Arq Neuropsiquiatr; 2001 Mar; 59(1):18-22. PubMed ID: 11299425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble intercellular adhesion molecule-I (sICAM-I) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system.
    Trojano M; Avolio C; Ruggieri M; De Robertis F; Giuliani F; Paolicelli D; Livrea P
    Mult Scler; 1998 Feb; 4(1):39-44. PubMed ID: 9532592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface bound and soluble adhesion molecules in CSF and blood in multiple sclerosis: correlation with MRI-measures of subclinical disease severity and activity.
    Kraus J; Engelhardt B; Chatzimanolis N; Bauer R; Tofighi J; Kuehne BS; Laske C; Stolz E; Frielinghaus P; Schaefer C; Blaes F; Traupe H; Kaps M; Oschmann P
    J Neuroimmunol; 2002 Jan; 122(1-2):175-85. PubMed ID: 11777557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.